Uludağ, Ö. Et Al. 2023. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?. Turkish Journal of Medical Sciences , vol.53, no.5 , 1067-1074.

Uludağ, Ö., ÇINAR, S., McDonnell, T., ÇENE, E., Yalçinkaya, Y., GÜL, A., ... İnanç, M.(2023). Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?. Turkish Journal of Medical Sciences , vol.53, no.5, 1067-1074.

Uludağ, Ömer Et Al. "Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?," Turkish Journal of Medical Sciences , vol.53, no.5, 1067-1074, 2023

Uludağ, Ömer Et Al. "Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?." Turkish Journal of Medical Sciences , vol.53, no.5, pp.1067-1074, 2023

Uludağ, Ö. Et Al. (2023) . "Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?." Turkish Journal of Medical Sciences , vol.53, no.5, pp.1067-1074.

@article{article, author={Ömer Uludağ Et Al. }, title={Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?}, journal={Turkish Journal of Medical Sciences}, year=2023, pages={1067-1074} }